| |
| |
| |
Cut Costs and Increase Profits | |
| |
| |
No Excuse for the Wastage | |
| |
| |
Front-Loaded Solution | |
| |
| |
Downsizing | |
| |
| |
Think Transnational | |
| |
| |
A Final Word | |
| |
| |
| |
Guidelines | |
| |
| |
Start with Your Reports | |
| |
| |
The Wrong Way | |
| |
| |
Keep It in the Computer | |
| |
| |
Don't Push the River | |
| |
| |
KISS | |
| |
| |
Plug the Holes as They Arise | |
| |
| |
Pay for Results, Not Intentions | |
| |
| |
Plan, Do, Then Check | |
| |
| |
| |
Plan | |
| |
| |
| |
Prescription for Success | |
| |
| |
Plan | |
| |
| |
| |
Predesign Phase | |
| |
| |
| |
Design the Trials | |
| |
| |
Do | |
| |
| |
| |
Obtain Regulatory Agency Approval for the Trials | |
| |
| |
| |
Form the Implementation Team | |
| |
| |
| |
Line Up Your Panel of Physicians | |
| |
| |
| |
Develop the Data Entry Software | |
| |
| |
| |
Test the Software | |
| |
| |
| |
Train | |
| |
| |
| |
Recruit Patients | |
| |
| |
| |
Set Up External Review Committees | |
| |
| |
| |
Conduct the Trials | |
| |
| |
| |
Develop Suite of Programs for Use in Data Analysis | |
| |
| |
| |
Analyze and Interpret the Data | |
| |
| |
Check | |
| |
| |
| |
Complete the Submission | |
| |
| |
| |
Staffing for Success | |
| |
| |
The People You Need | |
| |
| |
Design Team | |
| |
| |
Obtain Regulatory Approval for the Trials | |
| |
| |
Track Progress | |
| |
| |
Implementation Team | |
| |
| |
Develop Data Entry Software | |
| |
| |
Test the Software | |
| |
| |
Line Up Your Panel of Physicians | |
| |
| |
External Laboratories | |
| |
| |
Site Coordinators | |
| |
| |
External Review Committees | |
| |
| |
Recruit and Enroll Patients | |
| |
| |
Transnational Trials | |
| |
| |
Conduct the Trials | |
| |
| |
Programs for Data Analysis | |
| |
| |
Analyze and Interpret the Data | |
| |
| |
The People You Don't Need | |
| |
| |
For Further Information | |
| |
| |
| |
Design Decisions | |
| |
| |
Should the Study Be Performed? | |
| |
| |
Should the Trials Be Transnational? | |
| |
| |
Study Objectives | |
| |
| |
End Points | |
| |
| |
Secondary End Points | |
| |
| |
Should We Proceed with a Full-Scale Trial? | |
| |
| |
Tertiary End Points | |
| |
| |
Baseline Data | |
| |
| |
Who Will Collect the Data? | |
| |
| |
Quality Control | |
| |
| |
Study Population | |
| |
| |
Timing | |
| |
| |
Closure | |
| |
| |
Planned Closure | |
| |
| |
Unplanned Closure | |
| |
| |
Be Defensive. Review, Rewrite, Review Again | |
| |
| |
Checklist for Design | |
| |
| |
Budgets and Expenditures | |
| |
| |
For Further Information | |
| |
| |
| |
Trial Design | |
| |
| |
Baseline Measurements | |
| |
| |
Controlled Randomized Clinical Trials | |
| |
| |
Randomized Trials | |
| |
| |
Blocked Randomization | |
| |
| |
Stratified Randomization | |
| |
| |
Single- vs. Double-Blind Studies | |
| |
| |
Allocation Concealment | |
| |
| |
Exceptions to the Rule | |
| |
| |
Sample Size | |
| |
| |
Which Formula? | |
| |
| |
Precision of Estimates | |
| |
| |
Bounding Type I and Type II Errors | |
| |
| |
Equivalence | |
| |
| |
Software | |
| |
| |
Subsamples | |
| |
| |
Loss Adjustment | |
| |
| |
Number of Treatment Sites | |
| |
| |
Alternate Designs | |
| |
| |
Taking Cost into Consideration | |
| |
| |
For Further Information | |
| |
| |
| |
Exception Handling | |
| |
| |
Patient Related | |
| |
| |
Missed Doses | |
| |
| |
Missed Appointments | |
| |
| |
Noncompliance | |
| |
| |
Adverse Reactions | |
| |
| |
Reporting Adverse Events | |
| |
| |
When Do You Crack the Code? | |
| |
| |
Investigator Related | |
| |
| |
Lagging Recruitment | |
| |
| |
Protocol Deviations | |
| |
| |
Site-Specific Problems | |
| |
| |
Closure | |
| |
| |
Intent to Treat | |
| |
| |
Is Your Planning Complete? | |
| |
| |
| |
Do | |
| |
| |
| |
Documentation | |
| |
| |
Guidelines | |
| |
| |
Common Technical Document | |
| |
| |
Reporting Adverse Events | |
| |
| |
Initial Submission to the Regulatory Agency | |
| |
| |
Sponsor Data | |
| |
| |
Justifying the Study | |
| |
| |
Objectives | |
| |
| |
Patient Selection | |
| |
| |
Treatment Plan | |
| |
| |
Outcome Measures and Evaluation | |
| |
| |
Procedures | |
| |
| |
Clinical Follow-Up | |
| |
| |
Adverse Events | |
| |
| |
Data Management, Monitoring, Quality Control | |
| |
| |
Statistical Analysis | |
| |
| |
Investigator Responsibilities | |
| |
| |
Ethical and Regulatory Considerations | |
| |
| |
Study Committees | |
| |
| |
Appendixes | |
| |
| |
Sample Informed Consent Form | |
| |
| |
Procedures Manuals | |
| |
| |
Physician's Procedures Manual | |
| |
| |
Laboratory Guidelines | |
| |
| |
Interim Reports | |
| |
| |
Enrollment Report | |
| |
| |
Data in Hand | |
| |
| |
Adverse Event Report | |
| |
| |
Annotated Abstract | |
| |
| |
Final Reports(s) | |
| |
| |
Regulatory Agency Submissions | |
| |
| |
e-Subs | |
| |
| |
Journal Articles | |
| |
| |
For Further Information | |
| |
| |
| |
Recruiting and Retaining Patients and Physicians | |
| |
| |
Selecting Your Clinical Sites | |
| |
| |
Recruiting Physicians | |
| |
| |
Teaching Hospitals | |
| |
| |
Clinical Resource Centers | |
| |
| |
Look to Motivations | |
| |
| |
Physician Retention | |
| |
| |
Get the Trials in Motion | |
| |
| |
Patient Recruitment | |
| |
| |
Factors in Recruitment | |
| |
| |
Importance of Planning | |
| |
| |
Ethical Considerations | |
| |
| |
Mass Recruiting | |
| |
| |
Patient Retention | |
| |
| |
Ongoing Efforts | |
| |
| |
Run-In Period | |
| |
| |
Budgets and Expenditures | |
| |
| |
For Further Information | |
| |
| |
| |
Computer-Assisted Data Entry | |
| |
| |
Pre-Data Screen Development Checklist | |
| |
| |
Develop the Data Entry Software | |
| |
| |
Avoid Predefined Groupings in Responses | |
| |
| |
Screen Development | |
| |
| |
Radio Button | |
| |
| |
Pull-Down Menus | |
| |
| |
Type and Verify | |
| |
| |
When the Entries Are Completed | |
| |
| |
Audit Trail | |
| |
| |
Electronic Data Capture | |
| |
| |
Data Storage: CDISC Guidelines | |
| |
| |
Testing | |
| |
| |
Formal Testing | |
| |
| |
Stress Testing | |
| |
| |
Training | |
| |
| |
Reminder | |
| |
| |
Support | |
| |
| |
Budgets and Expenditures | |
| |
| |
For Further Information | |
| |
| |
| |
Data Management | |
| |
| |
Options | |
| |
| |
Flat Files | |
| |
| |
Hierarchical Databases | |
| |
| |
Network Database Model | |
| |
| |
Relational Database Model | |
| |
| |
Which Database Model? | |
| |
| |
Object-Oriented Databases | |
| |
| |
Clients and Servers | |
| |
| |
One Size Does Not Fit All | |
| |
| |
Combining Multiple Databases | |
| |
| |
A Recipe for Disaster | |
| |
| |
Transferring Data | |
| |
| |
Quality Assurance and Security | |
| |
| |
Maintaining Patient Confidentiality | |
| |
| |
Access to Files | |
| |
| |
Maintaining an Audit Trail | |
| |
| |
Security | |
| |
| |
For Further Information | |
| |
| |
| |
Are You Ready? | |
| |
| |
Pharmaceuticals/Devices | |
| |
| |
Software | |
| |
| |
Hardware | |
| |
| |
Documentation | |
| |
| |
Investigators | |
| |
| |
External Laboratories | |
| |
| |
Review Committees | |
| |
| |
Patients | |
| |
| |
Regulatory Agency | |
| |
| |
Test Phase | |
| |
| |
| |
Monitoring the Trials | |
| |
| |
Roles of the Monitors | |
| |
| |
Before the Trials Begin | |
| |
| |
Kick-Off Meetings | |
| |
| |
Duties During Trial | |
| |
| |
Site Visits | |
| |
| |
Between Visits | |
| |
| |
Other Duties | |
| |
| |
Maintaining Physician Interest in Lengthy Trials | |
| |
| |
| |
Managing the Trials | |
| |
| |
Recruitment | |
| |
| |
Supplies | |
| |
| |
Late and Incomplete Forms | |
| |
| |
Dropouts and Withdrawals | |
| |
| |
Protocol Violations | |
| |
| |
Adverse Events | |
| |
| |
Quality Control | |
| |
| |
Visualize the Data | |
| |
| |
Roles of the Committees | |
| |
| |
Termination and Extension | |
| |
| |
Extending the Trials | |
| |
| |
Budgets and Expenditures | |
| |
| |
For Further Information | |
| |
| |
| |
Data Analysis | |
| |
| |
Report Coverage | |
| |
| |
Understanding Data | |
| |
| |
Categories | |
| |
| |
Metric Data | |
| |
| |
Statistical Analysis | |
| |
| |
Categorical Data | |
| |
| |
Ordinal Data | |
| |
| |
Metric Data | |
| |
| |
An Example | |
| |
| |
Time-to-Event Data | |
| |
| |
Step By Step | |
| |
| |
The Study Population | |
| |
| |
Reporting Primary End Points | |
| |
| |
Exceptions | |
| |
| |
Adverse Events | |
| |
| |
Analytical Alternatives | |
| |
| |
When Statisticians Can't Agree | |
| |
| |
Testing for Equivalence | |
| |
| |
Simpson's Paradox | |
| |
| |
Estimating Precision | |
| |
| |
Bad Statistics | |
| |
| |
Using the Wrong Method | |
| |
| |
Deming Regression | |
| |
| |
Choosing the Most Favorable Statistic | |
| |
| |
Making Repeated Tests on the Same Data | |
| |
| |
Ad Hoc, Post Hoc Hypotheses | |
| |
| |
Interpretation | |
| |
| |
Documentation | |
| |
| |
For Further Information | |
| |
| |
A Practical Guide To Statistical Terminology | |
| |
| |
| |
Check | |
| |
| |
| |
Check | |
| |
| |
Closure | |
| |
| |
Patient Care | |
| |
| |
Data | |
| |
| |
Spreading the News | |
| |
| |
Postmarket Surveillance | |
| |
| |
Budget | |
| |
| |
Controlling Expenditures | |
| |
| |
Process Review Committee | |
| |
| |
Trial Review Committee | |
| |
| |
Investigatory Drug or Device | |
| |
| |
Interactions | |
| |
| |
Adverse Events | |
| |
| |
Collateral Studies | |
| |
| |
Future Studies | |
| |
| |
For Further Information | |
| |
| |
| |
Software | |
| |
| |
Choices | |
| |
| |
All In One | |
| |
| |
Almost All In One | |
| |
| |
Project Management | |
| |
| |
Data Entry | |
| |
| |
Handheld Devices | |
| |
| |
Touch Screen | |
| |
| |
Speech Recognition | |
| |
| |
e-CRFs | |
| |
| |
Do It Yourself | |
| |
| |
Data Collection Via the Web | |
| |
| |
Preparing the Common Technical Document | |
| |
| |
Data Management | |
| |
| |
Data Entry and Data Management | |
| |
| |
Small-Scale Clinical Studies | |
| |
| |
Clinical Database Managers | |
| |
| |
Data Analysis | |
| |
| |
Utilities | |
| |
| |
Sample Size Determination | |
| |
| |
Screen Capture | |
| |
| |
Data Conversion | |
| |
| |
Author Index | |
| |
| |
Subject Index | |